Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis

D T Connolly, D M Heuvelman, R Nelson, J V Olander, B L Eppley, J J Delfino, N R Siegel, R M Leimgruber, J Feder, D T Connolly, D M Heuvelman, R Nelson, J V Olander, B L Eppley, J J Delfino, N R Siegel, R M Leimgruber, J Feder

Abstract

Vascular permeability factor (VPF) is an Mr 40-kD protein that has been purified from the conditioned medium of guinea pig line 10 tumor cells grown in vitro, and increases fluid permeability from blood vessels when injected intradermally. Addition of VPF to cultures of vascular endothelial cells in vitro unexpectedly stimulated cellular proliferation. VPF promoted the growth of new blood vessels when administered into healing rabbit bone grafts or rat corneas. The identity of the growth factor activity with VPF was established in four ways: (a) the molecular weight of the activity in preparative SDS-PAGE was the same as VPF (Mr approximately 40 kD); (b) multiple isoforms (pI greater than or equal to 8) for both VPF and the growth-promoting activity were observed; (c) a single, unique NH2-terminal amino acid sequence was obtained; (d) both growth factor and permeability-enhancing activities were immunoadsorbed using antipeptide IgG that recognized the amino terminus of VPF. Furthermore, 125I-VPF was shown to bind specifically and with high affinity to endothelial cells in vitro and could be chemically cross-linked to a high-molecular weight cell surface receptor, thus demonstrating a mechanism whereby VPF can interact directly with endothelial cells. Unlike other endothelial cell growth factors, VPF did not stimulate [3H]thymidine incorporation or promote growth of other cell types including mouse 3T3 fibroblasts or bovine smooth muscle cells. VPF, therefore, appears to be unique in its ability to specifically promote increased vascular permeability, endothelial cell growth, and angio-genesis.

References

    1. Cancer Res. 1986 Nov;46(11):5629-32
    1. Prog Hemost Thromb. 1976;3:1-28
    1. Microvasc Res. 1986 May;31(3):288-305
    1. Nature. 1970 Aug 15;227(5259):680-5
    1. Nature. 1989 Apr 13;338(6216):557-62
    1. Nature. 1985 Jan 31-Feb 6;313(6001):402-4
    1. J Cell Physiol. 1985 Feb;122(2):323-32
    1. J Physiol. 1952 Oct;118(2):228-57
    1. J Oral Maxillofac Surg. 1988 May;46(5):391-8
    1. Lab Invest. 1984 Dec;51(6):635-42
    1. Biochemistry. 1986 Jun 17;25(12):3487-92
    1. Science. 1983 Feb 25;219(4587):983-5
    1. J Immunol. 1986 Sep 1;137(5):1735-42
    1. Adv Cancer Res. 1985;43:175-203
    1. Cancer Res. 1988 Apr 1;48(7):1920-5
    1. J Immunol. 1977 Feb;118(2):529-32
    1. Biochem J. 1973 Jul;133(3):529-39
    1. Cancer Res. 1971 May;31(5):587-9
    1. Cancer Res. 1984 Sep;44(9):3719-23
    1. Lab Invest. 1987 Dec;57(6):673-86
    1. In Vitro. 1982 Feb;18(2):99-107
    1. Anal Biochem. 1981 Nov 1;117(2):307-10
    1. Proc Natl Acad Sci U S A. 1984 Jan;81(2):357-61
    1. Transplant Proc. 1980 Sep;12(3 Suppl 1):49-53
    1. Proc Natl Acad Sci U S A. 1984 Nov;81(22):6963-7
    1. Proc Natl Acad Sci U S A. 1986 Apr;83(8):2448-52
    1. Annu Rev Biochem. 1979;48:193-216
    1. In Vitro Cell Dev Biol. 1986 Jan;22(1):51-6
    1. Science. 1987 Jan 23;235(4787):442-7
    1. Cancer Res. 1987 Jul 1;47(13):3528-32
    1. Anal Biochem. 1986 Jan;152(1):136-40
    1. In Vitro Cell Dev Biol. 1987 Jul;23(7):481-91

Source: PubMed

3
Subskrybuj